End­points 11 win­ner Li­for­di Im­munother­a­peu­tics: Us­ing an­ti­bod­ies to de­liv­er po­tent steroids di­rect­ly to im­mune cells

  • CEO Arthur Tzian­a­bos
  • To­tal raised $70 mil­lion
  • Head­quar­ters Burling­ton, MA

As a young sci­en­tist, Jay Roth­stein asked fel­low im­mu­nol­o­gists what …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA